Clinical Trials in Cleveland

Showing 141-160 of 19,775 trials

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

NCT06703489

Sphere-9 VT EFS is a prospective, multi-center, non-randomized, unblinded feasibility study. Adult subjects with recurrent, sustained, scar-related monomorphic ventricular tachycardia will be enrolled and treated with the Sphere-9 Catheter and Affera Ablation System.

Ventricular Tachycardia (VT)

Medtronic Cardiac Ablation Solutions60 participantsStarted Mar 2025

Boston, Massachusetts, United States • New York, New York, United States • Cleveland, Ohio, United States +3 more locations

Active Not RecruitingNA< 1 mile

TECTONIC CAD IVL IDE Study

NCT06885177

A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

Coronary Artery CalcificationCoronary Artery DiseaseStenotic Coronary Lesion

Abbott Medical Devices335 participantsStarted Apr 2025

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +37 more locations

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

TECTONIC CAD IVL IDE Study

Find Trials by Condition in Cleveland

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

Non-Narcotic Pain Control After ACL Reconstruction

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

Excimer Laser Trabeculostomy Glaucoma Treatment Study

Radiation Free Study

Clinical Procedures to Support Research in ALS

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

A Study of LY3971297 in Participants With Heart Failure

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function